The 17th annual
Westin Immunogenicity Seminar
Thursday, September 25, 2025 | 9:00 am – 6:00 pm | The Westin Hotel, Meguro, Tokyo
Join us for the 17th Annual Westin Immunogenicity Seminar, a free event bringing together leaders in immunology, biotech, and drug development. This year’s agenda will feature in-depth presentations on immunogenicity considerations for novel and rapidly advancing modalities, including CAR-T and gene therapies, multi-specific biologics, and AI-powered immunogenicity risk assessment platforms.
You’ll hear from distinguished speakers representing Johnson & Johnson, The RIKEN Center, The University of Osaka, and other global leaders in the field. The seminar includes ample opportunities for networking, a collaborative panel discussion to highlight key takeaways, and a closing reception that encourages continued connection over light refreshments.
We are pleased to announce that Vibha Jawa, PhD, FAAPS, EpiVax’s newly appointed Chief Scientific Officer, will be in attendance. With over two decades of leadership in biologics and gene therapy development, Dr. Jawa brings deep expertise in immunogenicity strategy and bioanalytical science. This seminar provides an excellent opportunity to meet her and learn about her vision for advancing EpiVax’s scientific leadership.
Designed for both academic and industry professionals, this annual gathering is a valuable forum for idea sharing, exploring research advances, and aligning on strategies that close the gap between biologic drug development and the latest in immunogenicity science.
Please note: This is an in-person event with no options for virtual attendance.
Organizing Committee:
Annie De Groot, MD Founder & Chief Medical Officer, EpiVax Inc.
Susumu Uchiyama, PhD Professor, Department of Biotechnology, The University of Osaka
Takuya Tsunoda, MD Professor, Medical Oncology, Showa University
Hiroki Shirai, PhD Coordinator, RIKEN Center for Computational Science. Visiting Professor, Faculty of Pharmaceutical Sciences, Kumamoto University.
Vibha Jawa, PhD Chief Scientific Officer, EpiVax, Inc.
Jochem Gokemeijer, PhD Distinguished Scientist, Biologics, Johnson & Johnson
Explore past year’s seminars!
And join us for the Tregs as Medicine: Tolerance and InTolerance Seminar on Friday, September 26th! More information and register |
